Latest News about TAK
Recent news which mentions TAK
Takeda Divests Four Diabetes Products In Japan To Teijin Pharma
February 26, 2021
From Benzinga
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
Takeda's Maribavir Hits Primary Endpoint Goal In Late-Stage Study In Transplant Recipients
February 12, 2021
From Benzinga
Can KalVista Pharmaceuticals Stock Fly Higher?
February 10, 2021
From Motley Fool
From Benzinga
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
February 06, 2021
From Benzinga
Why Moderna Is Shooting Higher Today
January 21, 2021
From Motley Fool
A Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth Through 2021
January 06, 2021
From Benzinga
From Benzinga
2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started
December 23, 2020
From Motley Fool
Why Nano-Cap Xenetic Biosciences Is Skyrocketing
December 09, 2020
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs
December 04, 2020
From Benzinga
How Much Can Companies Make From Coronavirus Vaccines?
December 02, 2020
From Motley Fool
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
From Benzinga
3 Best Biotech Stocks to Buy in November
November 18, 2020
From Motley Fool
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
From Benzinga
Moderna Q3 Revenues Beat Estimates, Inks Coronavirus Vaccine Supply Deal With Japan
October 29, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
From Benzinga
Earnings Scheduled For October 29, 2020
October 29, 2020
From Benzinga
The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings
October 27, 2020
From Benzinga
Takeda-Led Group Begins Manufacturing COVID-19 Plasma Treatment, Says Confident Of Efficacy
October 13, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Moderna Expands Into Switzerland, Tiziana To Spin Off Testing Unit, Metacrine IPO
September 16, 2020
From Benzinga
6 Companies Racing to Mass-Produce a Coronavirus Vaccine in 2021
September 09, 2020
From Motley Fool
Every Coronavirus Vaccine Deal Novavax Has Negotiated
September 01, 2020
From Benzinga
Can GW Pharmaceuticals Stock Bounce Back?
August 29, 2020
From Motley Fool
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.